Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Holdings in Global Medical REIT Inc. $GMRE

Universal Beteiligungs und Servicegesellschaft mbH reduced its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 80.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,613 shares of the company’s stock after selling 130,457 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned 0.24% of Global Medical REIT worth $1,099,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of GMRE. Peregrine Capital Management LLC bought a new stake in Global Medical REIT in the third quarter valued at $4,785,000. Nomura Asset Management Co. Ltd. boosted its stake in shares of Global Medical REIT by 2.9% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 88,000 shares of the company’s stock valued at $610,000 after purchasing an additional 2,500 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Global Medical REIT by 3.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,748,799 shares of the company’s stock valued at $12,121,000 after purchasing an additional 50,959 shares in the last quarter. Fox Run Management L.L.C. purchased a new position in shares of Global Medical REIT during the second quarter valued at about $183,000. Finally, Metis Global Partners LLC bought a new position in Global Medical REIT in the second quarter worth about $72,000. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Global Medical REIT Price Performance

Shares of NYSE:GMRE opened at $34.51 on Friday. Global Medical REIT Inc. has a 1-year low of $29.05 and a 1-year high of $45.75. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52. The business has a fifty day moving average price of $34.35 and a 200-day moving average price of $34.15. The company has a market capitalization of $462.78 million, a PE ratio of -138.04 and a beta of 1.18.

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.05 by $0.07. The company had revenue of $37.23 million for the quarter, compared to the consensus estimate of $38.15 million. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. As a group, equities analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.

Global Medical REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 8.7%. The ex-dividend date was Friday, December 19th. Global Medical REIT’s payout ratio is presently -1,200.00%.

Insider Transactions at Global Medical REIT

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 10,000 shares of the business’s stock in a transaction on Friday, November 14th. The shares were acquired at an average cost of $32.58 per share, for a total transaction of $325,800.00. Following the purchase, the chief executive officer owned 44,774 shares in the company, valued at approximately $1,458,736.92. This trade represents a 28.76% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 8.50% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on GMRE shares. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. JMP Securities set a $40.00 price target on Global Medical REIT and gave the stock a “market outperform” rating in a research note on Monday, October 13th. Citizens Jmp upgraded Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 price objective for the company in a report on Monday, October 13th. Robert W. Baird dropped their target price on shares of Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Finally, Weiss Ratings raised shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Global Medical REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.50.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.